Korea FilingsFull brief — $39

KOREAN DRUG CO., LTD.

고려제약(주) · KOSDAQ: 014570 · Pharmaceuticals and medicinal chemicals

Key facts

Korean name
고려제약(주)
Market / ticker
KOSDAQ · 014570
Industry
Pharmaceuticals and medicinal chemicals
Established
1980-01-10
Fiscal year ends
December
Website
www.nicepharma.com
DART corp code
00103015
Latest revenue
₩62.5B (FY2025)

Items worth checking

medium
Fine or penalty imposed — filed 2026-07-10.

Financial summary

KRWFY2023FY2024FY2025
Revenue₩81.4B₩73.0B₩62.5B
Operating income₩18.0B₩9.1B₩6.9B
Net income−₩4.9B₩3.0B₩6.5B
Total assets₩89.7B₩88.9B₩94.3B
Total liabilities₩12.6B₩10.8B₩11.2B
Total equity₩77.1B₩78.1B₩83.1B
Share capital₩5.5B₩5.5B₩5.5B

Separate statements · FY2025 operating margin 11.1% · liabilities to equity 14% · Annual report FY2025 (Korean original)

Auditor opinions

PeriodAuditorOpinion
Term 46 (current)대성회계법인Unqualified
Term 45 (prior)대성회계법인Unqualified
Term 44 (two years prior)대성회계법인Unqualified

Largest shareholder history

DateLargest shareholder (Korean)StakeCause (Korean)
2009년 04월 09일박상훈

Recent filings

DateFilingOriginal
2026-08-14Half-year report (2026.06)DART
2026-07-10Fine or penalty imposedDART
2026-05-19Treasury share disposal results reportDART
2026-05-18Material event report — Treasury share disposal decisionDART
2026-05-15Quarterly report (2026.03)DART
2026-04-30Market segment reassignmentDART
2026-04-07Treasury share disposal results reportDART
2026-03-31Material event report — Treasury share disposal decisionDART
2026-03-20Corporate value-up plan (voluntary)DART
2026-03-20Annual general meeting resultsDART
2026-03-12Attachment added: Annual report (2025.12)DART
2026-03-12Audit report submittedDART
2026-03-05Treasury share disposal results reportDART
2026-03-03Material event report — Treasury share disposal decisionDART
2026-02-25Proxy solicitation reference documentDART
2026-02-25Notice of shareholders meetingDART
2026-02-24Resolution to convene shareholders meetingDART
2026-02-24Cash / in-kind dividend decisionDART
2026-02-24Revenue or profit structure changed materiallyDART
2026-01-07Treasury share disposal results reportDART

Showing the 20 most recent of 23 filings. The full brief lists all of them.

Full brief on KOREAN DRUG CO., LTD. — $39 Get the full brief

For business customers. EU companies: enter your VAT number at checkout and no VAT is charged (reverse charge).

Other Korean companies in Pharmaceuticals and medicinal chemicals

Data generated 2026-09-16 from OpenDART.

This page summarizes public filings from DART, the official electronic disclosure system of Korea. It is not investment, credit or legal advice. Figures are shown in the currency the company reports in. Titles and labels are machine-translated and may contain errors — always check the linked original filing. Source: OpenDART, Financial Supervisory Service, Korea.